Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and liver diseases, today announced the appointment of. | August 8, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
Enanta Pharmaceuticals Announces the Appointment of Brendan Luu as Senior Vice President, Business Development
January 26, 2021 GMT
Brendan Luu, Senior Vice President, Business Development, Enanta Pharmaceuticals (Photo: Business Wire)
WATERTOWN, Mass. (BUSINESS WIRE) Jan 26, 2021
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced the appointment of Brendan Luu as Senior Vice President, Business Development and member of the company’s senior management team. Mr. Luu brings more than 20 years of diversified business development and sales and marketing experience in the pharmaceutical and technology fields to Enanta, spanning a broad range of therapeutic areas, asset stages and deal structures.